Clinical Trial: Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure

U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07326631) titled 'Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure' on Dec. 09, 2025.

Brief Summary: To assess the effect of Finerinone on slowing renal function decline and improving cardiovascular outcomes, particularly heart failure risk, in patients with diabetic CKD.

Study Start Date: Jan. 01

Study Type: INTERVENTIONAL

Condition: Diabetic Kidney Disease (DKD) Heart Failure

Intervention: DRUG: Finerenone

To assess the effect of Finerinone on slowing renal function decline and improving cardiovascular outcomes, particularly heart failure risk, in patients with diabetic CKD.

Recruitmen...